Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression
Cancer Immunology, Immunotherapy · 14.03.2026 · 75 (4)
DOI: 10.1007/s00262-026-04358-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 14.03.2026. Verfasst von Qianqian Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Th17 Cells, Mast Cells, Lung Neoplasms, Macrophage Migration-Inhibitory Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, the Key Technologies R&D Program of Songjiang District, Shanghai.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Clinical Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, China.
- Precision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,…
- State Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China. zhengfeng.yang@shgh.cn.
- Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. xiaohui771210@163.com.
Förderung
- National Natural Science Foundation of China
- the Key Technologies R&D Program of Songjiang District, Shanghai
Zitieren
APA
Peng, Q., Ye, X., Xu, X., Song, J., Yang, Z., & Xiao, H. (2026). Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression. Cancer Immunology, Immunotherapy, 75(4). https://doi.org/10.1007/s00262-026-04358-3
Vancouver
Peng Q, Ye X, Xu X, Song J, Yang Z, Xiao H. Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression. Cancer Immunology, Immunotherapy. 2026;75(4). doi:10.1007/s00262-026-04358-3
BibTeX
@article{Peng2026,
author = {Peng, Qianqian and Ye, Xiong and Xu, Xingyi and Song, Jinghan and Yang, Zhengfeng and Xiao, Hui},
title = {Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {4},
doi = {10.1007/s00262-026-04358-3}
}
EUVIMED